OFIX

SEC source: 0001209191-24-001245 · doc4.xml · nonDerivative · entry 2

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,998

F2 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F1 · balance_after: Includes 157,609 previously reported unvested restricted stock units.

SEC source: 0001209191-24-001366 · doc4.xml · derivative · entry 2

Calafiore Massimo · CIK 0001828602 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,005

Underlying: Common Stock · 392,005 shares

Expires 2031-01-08

F2 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date, subject in each case to an additional vesting requirement related to the performance of the Company's common stock.

SEC source: 0001209191-24-001366 · doc4.xml · nonDerivative · entry 1

Calafiore Massimo · CIK 0001828602 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,084

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

SEC source: 0001209191-24-001363 · doc4.xml · derivative · entry 3

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,959 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achievement of an operating expense synergy target (on an annualized basis) for calendar year 2023 (the "Synergy Target"). The amount in the table above represents the target number of PSUs granted. The synergy target vesting percentage can be achieved at 100% (if 100% or more of the Synergy Target is achieved), 80% (if 80% but less than 100% of the Synergy target is achieved), or 0% (if less than 80% of the Synergy Target is achieved).

F2 · derivative.expiration_date: Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achievement of an operating expense synergy target (on an annualized basis) for calendar year 2023 (the "Synergy Target"). The amount in the table above represents the target number of PSUs granted. The synergy target vesting percentage can be achieved at 100% (if 100% or more of the Synergy Target is achieved), 80% (if 80% but less than 100% of the Synergy target is achieved), or 0% (if less than 80% of the Synergy Target is achieved).

SEC source: 0001209191-24-001363 · doc4.xml · nonDerivative · entry 2

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,810

SEC source: 0001209191-24-001363 · doc4.xml · nonDerivative · entry 1

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,321

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 4, 2023, the reporting person was granted 5,959 performance-based restricted stock units (PSUs). Such PSUs vested and converted to common stock on a one-for-one basis on January 8, 2024.

SEC source: 0001209191-24-001274 · doc4.xml · nonDerivative · entry 1

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,362

F1 · balance_after: Includes 94,711 previously reported unvested restricted stock units.

SEC source: 0001209191-24-001272 · doc4.xml · nonDerivative · entry 1

Gillespie Geoffrey C · CIK 0001993483 · VP, Controller, Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,682

F1 · balance_after: Includes 31,423 previously reported unvested restricted stock units.

SEC source: 0001209191-24-001245 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,187

F1 · balance_after: Includes 157,609 previously reported unvested restricted stock units.

SEC source: 0001209191-24-001032 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,415

F1 · balance_after: Includes 169,318 previously reported unvested restricted stock units.

SEC source: 0001209191-23-059391 · doc4.xml · derivative · entry 1

Kummeth Charles R. · CIK 0001534980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,652

Underlying: Common Stock · 47,652 shares

Expires 2033-12-18

F1 · derivative.exercise_date: The stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, December 18, 2023.

SEC source: 0001209191-23-059392 · doc4.xml · derivative · entry 1

BURRIS WAYNE · CIK 0001885420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,652

Underlying: Common Stock · 47,652 shares

Expires 2033-12-18

F1 · derivative.exercise_date: The stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, December 18, 2023.

SEC source: 0001209191-23-059353 · doc4.xml · derivative · entry 2

Bazaar Alan Lee · CIK 0001296974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,652

Underlying: Common Stock · 47,652 shares

Expires 2033-12-18

F2 · derivative.exercise_date: The stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, December 18, 2023.

SEC source: 0001209191-23-059353 · doc4.xml · nonDerivative · entry 1

Bazaar Alan Lee · CIK 0001296974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · shares: In connection with the stock option grant described in Table II below, the Board of the Issuer cancelled the deferred stock unit grant previously made to reporting person on December 12, 2023.

SEC source: 0001209191-23-059343 · doc4.xml · derivative · entry 1

Finegan Michael · CIK 0001391402 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,652

Underlying: Common Stock · 47,652 shares

Expires 2033-12-18

F1 · derivative.exercise_date: The stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, December 18, 2023.

SEC source: 0001209191-23-059160 · doc4.xml · nonDerivative · entry 1

Gillespie Geoffrey C · CIK 0001993483 · VP, Controller, Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,141

F1 · balance_after: Includes 32,974 previously reported unvested restricted stock units.

SEC source: 0001209191-23-058685 · doc4.xml · nonDerivative · entry 1

Bazaar Alan Lee · CIK 0001296974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,936

F1 · shares: Represents an award of deferred stock units that vest in full on the earlier of (i) June 30, 2024 or (ii) the date on which the issuer holds its 2024 annual meeting of stockholders, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

SEC source: 0001209191-23-057614 · doc4.xml · nonDerivative · entry 1

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,317

F1 · balance_after: Includes 115,164 previously reported unvested restricted stock units.

SEC source: 0001209191-23-056400 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 227,193

F1 · shares: Represents time-based vesting restricted stock units that vest in full on the second anniversary of grant date.

F2 · balance_after: Includes 184,756 outstanding restricted stock units and 42,437 shares owned directly.

SEC source: 0001209191-23-052981 · doc4.xml · nonDerivative · entry 1

Gillespie Geoffrey C · CIK 0001993483 · VP, Controller, Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,074

F1 · shares: Represents time-based vesting restriced stock units that vest in full on the second anniversary of grant date.

F2 · balance_after: Includes 9,743 previously reported restricted stock units.

SEC source: 0001209191-23-052979 · doc4.xml · nonDerivative · entry 1

Leekha Puja · CIK 0001993571 · CECO & Interim CLO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,316

F1 · shares: Represents time-based vesting restriced stock units that vest in full on the second anniversary of grant date.

F2 · balance_after: Includes 15,136 previously reported restricted stock units.

SEC source: 0001209191-23-052978 · doc4.xml · nonDerivative · entry 1

BURZIK CATHERINE M · CIK 0001261141 · Director · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,625

F1 · shares: The restricted stock units vest in full ninety (90) calendar days following the date that a successor Chief Executive Officer of Issuer assumes office following the Reporting Person's discontinuation of service as Interim Chief Executive Officer of Issuer.

F2 · balance_after: Includes 32,763 previously reported deferred stock units.

SEC source: 0001209191-23-049458 · doc4.xml · nonDerivative · entry 1

Hinrichs James F. · CIK 0001506974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,153

F1 · price: Reflects the weighted average purchase price. The range of prices for these transactions was $13.46 to $13.48. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

F2 · balance_after: Includes 39,548 deferred stock units.

SEC source: 0001209191-23-038789 · doc4.xml · nonDerivative · entry 1

BURZIK CATHERINE M · CIK 0001261141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,949

F1 · price: Represents an award of deferred stock units that vest in full on the earlier of (i) June 30, 2024 or (ii) the date on which the issuer holds its 2024 annual meeting of stockholders, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

F2 · balance_after: Includes 32,763 deferred stock units.

F3 · balance_after: Includes 1,304 shares purchased by the reporting person, on April 30, 2023, under the Orthofix Medical Inc. Second Amended and Restated Stock Purchase Plan, in a transaction exempt under Rule 16b-3(c).

SEC source: 0001209191-23-038781 · doc4.xml · nonDerivative · entry 1

BURRIS WAYNE · CIK 0001885420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,546

F1 · price: Represents an award of deferred stock units that vest in full on the earlier of (i) June 30, 2024 or (ii) the date on which the issuer holds its 2024 annual meeting of stockholders, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

F2 · balance_after: Includes 10,163 deferred stock units.

SEC source: 0001209191-23-032678 · doc4.xml · nonDerivative · entry 2

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,431

F1 · balance_after: Includes 117,667 previously reported restricted stock units.

SEC source: 0001209191-23-032678 · doc4.xml · nonDerivative · entry 1

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,307

F1 · balance_after: Includes 117,667 previously reported restricted stock units.

SEC source: 0001209191-23-024131 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,841

F1 · balance_after: Includes 137,092 previously reported unvested restricted stock units.

SEC source: 0001209191-23-024129 · doc4.xml · nonDerivative · entry 1

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,087

F1 · balance_after: Includes 117,667 previously reported unvested restricted stock units.

SEC source: 0001209191-23-023453 · doc4.xml · derivative · entry 4

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,061

Underlying: Common Stock · 17,061 shares

Expires 2033-04-04

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0001209191-23-023453 · doc4.xml · derivative · entry 3

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,959

Underlying: Common Stock · 5,959 shares

Expires not disclosed

F2 · derivative.exercise_date: Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achievement of an operating expense synergy target (on an annualized basis) for calendar year 2023 (the "Synergy Target"). The amount in the table above represents the target number of PSUs granted. The Synergy Target vesting percentage can be achieved at 100% (if 100% or more of the Synergy Target is achieved), 80% (if 80% but less than 100% of the Synergy Target is achieved), or 0% (if less than 80% of the Synergy Target is achieved).

F2 · derivative.expiration_date: Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achievement of an operating expense synergy target (on an annualized basis) for calendar year 2023 (the "Synergy Target"). The amount in the table above represents the target number of PSUs granted. The Synergy Target vesting percentage can be achieved at 100% (if 100% or more of the Synergy Target is achieved), 80% (if 80% but less than 100% of the Synergy Target is achieved), or 0% (if less than 80% of the Synergy Target is achieved).

SEC source: 0001209191-23-023453 · doc4.xml · nonDerivative · entry 2

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,724

F1 · balance_after: Includes 121,401 previously reported unvested restricted stock units.

SEC source: 0001209191-23-023453 · doc4.xml · nonDerivative · entry 1

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,275

SEC source: 0001209191-23-023448 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,779

F1 · balance_after: Includes 144,560 previously reported unvested restricted stock units.

SEC source: 0001209191-23-023445 · doc4.xml · nonDerivative · entry 1

Serbousek Jon Carl · CIK 0001536875 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,827

F1 · balance_after: Includes 268,554 previously reported unvested restricted stock units.

SEC source: 0001209191-23-023450 · doc4.xml · nonDerivative · entry 1

Maniar Shweta · CIK 0001850826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,080

F1 · balance_after: Includes 14,354 previoiusly reported deferred stock units.

SEC source: 0001209191-23-014703 · doc4.xml · nonDerivative · entry 1

Bostjancic John J. · CIK 0001644860 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,670

F1 · balance_after: Includes 52,384 unvested restricted stock units.

SEC source: 0001209191-23-014687 · doc4.xml · nonDerivative · entry 1

Valentine Keith · CIK 0001289408 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 377,741

F1 · balance_after: Includes 217,134 unvested restricted stock units.

SEC source: 0001209191-23-014680 · doc4.xml · nonDerivative · entry 1

Keran Patrick L · CIK 0001372290 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,407

F1 · balance_after: Includes 51,285 unvested restricted stock units.

SEC source: 0001209191-23-007207 · doc4.xml · nonDerivative · entry 1

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,231

F1 · balance_after: Includes 118,926 shares of unvested restricted stock units.

SEC source: 0001209191-23-007205 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,164

F1 · balance_after: Includes 150,626 shares of unvested restricted stock units.

SEC source: 0001209191-23-007203 · doc4.xml · nonDerivative · entry 1

Serbousek Jon Carl · CIK 0001536875 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,968

F1 · balance_after: Includes 287,130 shares of unvested restricted stock units.

SEC source: 0001209191-23-006009 · doc4.xml · nonDerivative · entry 1

Valentine Keith · CIK 0001289408 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 394,031

F1 · balance_after: Includes 249,991 unvested restricted stock units.

SEC source: 0001209191-23-006002 · doc4.xml · nonDerivative · entry 1

Keran Patrick L · CIK 0001372290 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,199

F1 · balance_after: Includes 58,513 unvested restricted stock units.

SEC source: 0001209191-23-006005 · doc4.xml · nonDerivative · entry 1

Bostjancic John J. · CIK 0001644860 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,453

F1 · balance_after: Includes 59,571 unvested restricted stock units.

SEC source: 0001209191-24-001245 · doc4.xml · derivative · entry 3

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,867

Underlying: Common Stock · 43,867 shares

Expires 2031-01-08

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0001209191-23-002670 · doc4.xml · derivative · entry 5

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,146

Underlying: Common Stock · 72,146 shares

Expires 2033-01-05

F6 · derivative.exercise_date: The option vests in four equal installments on each of January 5, 2023, January 5, 2024, January 5, 2025 and January 5, 2026.

SEC source: 0001209191-23-002670 · doc4.xml · nonDerivative · entry 4

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,518

F4 · shares: Represents outstanding performance stock units for awards granted in 2022, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on January 31, 2025.

F5 · balance_after: Includes 124,049 unvested restricted stock units.

SEC source: 0001209191-23-002670 · doc4.xml · nonDerivative · entry 3

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,026

F3 · shares: Represents outstanding performance stock units for awards granted in 2021, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on April 1, 2024.

SEC source: 0001209191-23-002670 · doc4.xml · nonDerivative · entry 2

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,797

F2 · shares: Represents outstanding performance stock units for awards granted in 2020, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on June 8, 2023.